(19)
(11) EP 3 953 381 A1

(12)

(43) Date of publication:
16.02.2022 Bulletin 2022/07

(21) Application number: 20728119.7

(22) Date of filing: 09.04.2020
(51) International Patent Classification (IPC): 
C07K 16/00(2006.01)
C12N 15/62(2006.01)
G01N 33/564(2006.01)
G01N 33/563(2006.01)
C12N 9/02(2006.01)
G01N 33/533(2006.01)
G01N 33/577(2006.01)
C12Q 1/66(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/241; C07K 2317/622; C12N 2800/22; C12Q 1/66; G01N 33/563; C07K 16/00; C07K 16/2893; C07K 16/2887; C07K 2319/61; C07K 2319/21; C07K 16/32; C07K 2319/00; C07K 16/36
(86) International application number:
PCT/GB2020/050940
(87) International publication number:
WO 2020/208372 (15.10.2020 Gazette 2020/42)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 10.04.2019 GB 201905100

(71) Applicant: ASK Bioinnovations Ltd
London, Greater London E10 6DR (GB)

(72) Inventor:
  • KANG, Angray Singh
    London Greater London E10 6DR (GB)

(74) Representative: London IP Ltd 
100 High street Milford on Sea
Lymington, Hampshire SO41 0QE
Lymington, Hampshire SO41 0QE (GB)

   


(54) FUSION PROTEIN COMPRISING NANOLUCIFERASE INSERTED BETWEEN IMMUNOGLOBULIN VARIABLE DOMAINS